Skip to main content
Home
About Us
About Compugen
Leadership
Board of Directors
Scientific and Strategic Advisory Board
Contact Us
Our Science
Unigen™
Pipeline
Clinical Trials
Publications
Investors and Media
Overview
Press Releases
Events
Stock Information
NASDAQ: CGEN
TASE: CGEN.TA
Analyst Coverage
Financials
Quarterly Results, Annual Reports and Proxy
SEC Filings
Media
Governance
Governance Documents
Leadership
Committee Composition
Investor Contacts
Investor FAQs
Corporate Presentation
Collaborations
Careers
Follow Us
LinkedIn
X
Email Alerts
News Details
View All News
Potential of PVRIG and TIGIT blockade in addressing immunotherapy resistance
September 30, 2022
Download
(opens in new window)
Eran Ophir, Immuno UK, London, UK, 30 September 2022
View All News